Treatment of Relapsed Refractory Chronic Lymphocytic Leukemia After BTK Inhibitor and Or BCL-2 Inhibitor Failure. Can Hematol Today 2024, 3 (2), 49–53. https://doi.org/10.58931/cht.2024.3255.